April 26, 2013

Generic drug maker Actavis is settling a patent-infringement suit with Purdue Pharma concerning the opioid painkiller OxyContin, Actavis said, saying it expected to make more than $100 million in the deal between 2014 and 2015.

April 26, 2013

Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.

April 26, 2013

More than 1.3 million emergency room visits in 2010 were related to abuse of prescription drugs, and the problem has become widespread enough that the Centers for Disease Control and Prevention classifies it as an epidemic. In response, curbing abuse of prescription drugs has become a cornerstone of the Obama administration's drug policy.

April 25, 2013

Actavis can launch a generic version of an attention deficit hyperactivity disorder drug made by Shire next year under an agreement between the two companies announced Thursday.

April 25, 2013

Greenstone has launched an authorized generic painkiller, the company said.

April 25, 2013

The House Committee on Energy and Commerce Subcommittee on Health heard testimony on Thursday morning from representatives of the Food and Drug Administration and several industry trade groups following the introduction of draft legislation that sponsors said would strengthen the country's pharmaceutical supply chain.

April 24, 2013

Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

April 24, 2013

A dramatic jump in the rates of misuse of prescription stimulants over the past four years is linked to lax attitudes on the part of parents, according to a new study, though misuse and abuse of prescription opioids has remained flat.

April 23, 2013

The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

April 23, 2013

Unnecessary spending related to medications totaled nearly half a trillion dollars last year, and much of that was in the poorest states in the country, according to pharmacy benefit manager Express Scripts.

April 23, 2013

Sandoz U.S. Generics Operating Unit VP sales and marketing Rich Tremonte will leave the company.

April 19, 2013

The Food and Drug Administration has given tentative approval to two generic diabetes drugs made by Sun Pharmaceutical Industries, the Indian drug maker said.

April 19, 2013

A report released yesterday by the Bipartisan Policy Center, entitled “A Bipartisan Rx for Patient-Centered Care and System-Wide Cost Containment,” contains a smart, forward-looking and no-cost recommendation that could save the government billions, the Generic Pharmaceutical Association said.

April 18, 2013

A federal court ruling has allowed Actavis to relaunch a generic contraceptive drug, the company said.

April 18, 2013

Generic drug maker Hospira has appointed Matt Stober as its SVP operations, the company said.

April 18, 2013

A new study by Kaiser Permanente finds that a large percentage of women with osteoporosis fail to pick up new prescriptions for the condition.

April 17, 2013

Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.

April 16, 2013

Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.

April 16, 2013

The Food and Drug Administration will not approve generic versions of Purdue Pharma's painkiller OxyContin based on earlier versions of the drug that did not include features to thwart abuse, the agency said.

April 15, 2013

Generic makers heralded the fiscal year 2014 budget proposed last week by the Obama administration for its embrace of generic drugs, but were critical of its provisions on patent settlements and rebates.

April 15, 2013

The governor of North Dakota has signed into law a bill that would require pharmacy benefit managers to inform pharmacies about how reimbursement for generic prescription drugs is calculated under maximum allowable cost benchmarks and provide a more detailed appeals process to pharmacies to contest the MAC reimbursement caps that PBMs set up.

April 12, 2013

Drug companies' pharmaceutical portfolio management teams spend most of their time and budgets supporting niche products, according to a new study.

April 12, 2013

The Food and Drug Administration has approved a contraceptive therapy made by Lupin Pharmaceuticals, the Indian drug maker said Friday.

April 12, 2013

A proposal to further reduce Medicaid drug reimbursement that was included in President Obama’s fiscal year 2014 budget plan is “premature” and federal Medicaid officials should focus on modifying and completing already proposed regulations to set future federal upper limits for reimbursement of most generic drugs, the National Association of Chain Drug Stores and the National Community Pharmacists Association said.